![Neena Patil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neena Patil
Direktor/Vorstandsmitglied bei
TELEFLEX INCORPORATED
Vermögen: 13 Mio $ am 31.05.2026
Profil
Neena M.
Patil is currently Independent Director at Teleflex, Inc. since 2022.
Ms. Patil is Director at mothers2mothers.
Ms. Patil is Director at Princeton Medical Center Foundation since 2015.
Ms. Patil is Chief Legal Officer & Executive Vice President at Jazz Pharmaceuticals, Inc. since 2019.
Ms. Patil is Chief Legal Officer & Executive Vice President at Jazz Pharmaceuticals Plc since 2022.
Formerly, Ms. Patil was Secretary, General Counsel & Senior Vice President at Abeona Therapeutics, Inc. from 2018 to 2019.
Ms. Patil was VP-Legal Affairs & Associate General Counsel at Novo Nordisk, Inc. from 2008 to 2016.
Education includes a graduate degree from the University of Michigan conferred in 1999 and an undergraduate degree from Georgetown University conferred in 1996.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 51 549 ( 0,08 % ) | 12 Mio $ | 31.05.2026 | |
TELEFLEX INCORPORATED 0,01 % | 15.05.2026 | 3 716 ( 0,01 % ) | 478 026 $ | 31.05.2026 |
Aktive Positionen von Neena Patil
| Unternehmen | Position | Beginn |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | General Counsel | 01.07.2019 |
| TELEFLEX INCORPORATED | Direktor/Vorstandsmitglied | 29.04.2022 |
Princeton Medical Center Foundation | Direktor/Vorstandsmitglied | 01.01.2015 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | General Counsel | 01.07.2019 |
mothers2mothers
 mothers2mothers Miscellaneous Commercial ServicesCommercial Services Operates an non-governmental organization that prevents mother to child transmission of human immunodeficiency virus | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Neena Patil
| Unternehmen | Position | Ende |
|---|---|---|
| ABEONA THERAPEUTICS INC. | General Counsel | 01.07.2019 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | General Counsel | 01.10.2016 |
Ausbildung von Neena Patil
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
97
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Teleflex, Inc.
 Teleflex, Inc. Medical SpecialtiesHealth Technology Provides medical devices for critical care, urology and surgery | Health Technology |
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
mothers2mothers
mothers2mothers Miscellaneous Commercial ServicesCommercial Services Operates an non-governmental organization that prevents mother to child transmission of human immunodeficiency virus | Commercial Services |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Princeton Medical Center Foundation |
